Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Internal Medicine
•
Hematology
•
Sickle Cell
•
Pediatric Hematology
•
Benign Hematology
•
Stem Cell Transplantation
What subset of sickle cell disease patients are you offering sickle cell disease gene therapy?
Answer from: at Academic Institution
All patients with Hgb SS and patients with Hgb SC who have had any significant complications, excluding chronic pain.
Sign in or Register to read more
22690
Related Questions
How do you counsel sickle cell patients on the use of G-CSF to treat neutropenia from other causes, like malignancy?
How would you approach secondary stroke prevention in an adult with Hemoglobin SC disease?
Is there any indication for hydroxyurea in patients with sickle cell trait?
Would you consider continuing or re-trialing hydroxyurea for sickle cell patients after development of a leg ulcer?
Is there any benefit of using aspirin to mitigate VTE risk in testosterone-induced polycythemia?
For von Willebrand type 2B, do you expect a decline in platelet count over time as vWF increases with age?
What would you recommend for long term management of extensive dural venous sinus thrombosis (CVST) in young females when the only provoking risk factor is combined OCP?
What is your strategy for optimizing hydroxyurea dosage in patients with symptomatic sickle cell disease, particularly for genotypes HbSS and HbS/Beta thal?
How would you approach post-operative VTE prophylaxis for renal transplant in patients with a prior history of provoked VTE?
How do you approach the work-up for a patient with iron deficiency anemia who is not responding to oral iron therapy?